These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8244252)

  • 1. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection.
    Kurosaki M; Enomoto N; Marumo F; Sato C
    Hepatology; 1993 Dec; 18(6):1293-9. PubMed ID: 8244252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence variations of the hypervariable region of hepatitis C virus and their clinical significance.
    Zhang S; Wang W; Zhou K; Liu H
    Chin Med J (Engl); 2000 Dec; 113(12):1075-9. PubMed ID: 11776139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients.
    Booth JC; Kumar U; Webster D; Monjardino J; Thomas HC
    Hepatology; 1998 Jan; 27(1):223-7. PubMed ID: 9425941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C.
    Kurosaki M; Enomoto N; Marumo F; Sato C
    Virology; 1994 Nov; 205(1):161-9. PubMed ID: 7975211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection.
    Higashi K; Tsukiyama-Kohara K; Tanaka T; Tanaka E; Kiyosawa K; Kohara M
    Arch Virol; 2005 May; 150(5):883-98. PubMed ID: 15662481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T
    Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients.
    Kanazawa Y; Hayashi N; Mita E; Li T; Hagiwara H; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Nov; 20(5):1121-30. PubMed ID: 7523271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.
    Brambilla S; Bellati G; Asti M; Lisa A; Candusso ME; D'Amico M; Grassi G; Giacca M; Franchini A; Bruno S; Ideo G; Mondelli MU; Silini EM
    Hepatology; 1998 Jun; 27(6):1678-86. PubMed ID: 9620342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
    Yamamoto C; Enomoto N; Kurosaki M; Yu SH; Tazawa J; Izumi N; Marumo F; Sato C
    Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain.
    Sherman KE; Andreatta C; O'Brien J; Gutierrez A; Harris R
    Hepatology; 1996 Apr; 23(4):688-94. PubMed ID: 8666318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-alpha therapy.
    Yeh BI; Han KH; Oh SH; Kim HS; Hong SH; Oh SH; Kim YS
    J Med Virol; 1996 Jun; 49(2):95-102. PubMed ID: 8991943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic typing of hepatitis C viruses from Korean patients: implications of genome variation in the E2/NS1 region.
    Cho SH; Yoon JI; Chang JE; Ahn BM; Lee CH; Lee YI
    Biochem Biophys Res Commun; 1993 Oct; 196(2):780-8. PubMed ID: 8240354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus after interferon treatment has the variation in the hypervariable region of envelope 2 gene.
    Enomoto N; Sato C; Kurosaki M; Marumo F
    J Hepatol; 1994 Feb; 20(2):252-61. PubMed ID: 8006407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inferred hepatitis C virus quasispecies diversity is influenced by choice of DNA polymerase in reverse transcriptase-polymerase chain reactions.
    Mullan B; Kenny-Walsh E; Collins JK; Shanahan F; Fanning LJ
    Anal Biochem; 2001 Feb; 289(2):137-46. PubMed ID: 11161307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection with GB virus C in patients with chronic liver disease.
    Sugai Y; Nakayama H; Fukuda M; Sawada N; Tanaka T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
    J Med Virol; 1997 Mar; 51(3):175-81. PubMed ID: 9139080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.
    Kato N; Yokosuka O; Hosoda K; Ito Y; Ohto M; Omata M
    Hepatology; 1993 Jul; 18(1):16-20. PubMed ID: 8392026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.